These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35998269)

  • 1. Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans.
    Chen ZZ; Pacheco JA; Gao Y; Deng S; Peterson B; Shi X; Zheng S; Tahir UA; Katz DH; Cruz DE; Ngo D; Benson MD; Robbins JM; Guo X; Del Rocio Sevilla Gonzalez M; Manning A; Correa A; Meigs JB; Taylor KD; Rich SS; Goodarzi MO; Rotter JI; Wilson JG; Clish CB; Gerszten RE
    Diabetes; 2022 Nov; 71(11):2426-2437. PubMed ID: 35998269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study.
    Cruz DE; Tahir UA; Hu J; Ngo D; Chen ZZ; Robbins JM; Katz D; Balasubramanian R; Peterson B; Deng S; Benson MD; Shi X; Dailey L; Gao Y; Correa A; Wang TJ; Clish CB; Rexrode KM; Wilson JG; Gerszten RE
    JAMA Cardiol; 2022 Feb; 7(2):184-194. PubMed ID: 34851361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study.
    Zheng Y; Yu B; Alexander D; Manolio TA; Aguilar D; Coresh J; Heiss G; Boerwinkle E; Nettleton JA
    Am J Epidemiol; 2013 Aug; 178(4):534-42. PubMed ID: 23788672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Markers of Diabetes Discovered in an African American Cohort.
    Chen ZZ; Gao Y; Keyes MJ; Deng S; Mi M; Farrell LA; Shen D; Tahir UA; Cruz DE; Ngo D; Benson MD; Robbins JM; Correa A; Wilson JG; Gerszten RE
    Diabetes; 2023 Apr; 72(4):532-543. PubMed ID: 36630488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes.
    Ottosson F; Smith E; Gallo W; Fernandez C; Melander O
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4921-4930. PubMed ID: 31502646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic profiling of glucose homeostasis in African Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS-FS).
    Okut H; Lu Y; Palmer ND; Chen YI; Taylor KD; Norris JM; Lorenzo C; Rotter JI; Langefeld CD; Wagenknecht LE; Bowden DW; Ng MCY
    Metabolomics; 2023 Apr; 19(4):35. PubMed ID: 37005925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.
    Fall T; Salihovic S; Brandmaier S; Nowak C; Ganna A; Gustafsson S; Broeckling CD; Prenni JE; Kastenmüller G; Peters A; Magnusson PK; Wang-Sattler R; Giedraitis V; Berne C; Gieger C; Pedersen NL; Ingelsson E; Lind L
    Diabetologia; 2016 Oct; 59(10):2114-24. PubMed ID: 27406814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.
    Menni C; Fauman E; Erte I; Perry JR; Kastenmüller G; Shin SY; Petersen AK; Hyde C; Psatha M; Ward KJ; Yuan W; Milburn M; Palmer CN; Frayling TM; Trimmer J; Bell JT; Gieger C; Mohney RP; Brosnan MJ; Suhre K; Soranzo N; Spector TD
    Diabetes; 2013 Dec; 62(12):4270-6. PubMed ID: 23884885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolites associated with wholegrain consumption using nontargeted metabolic profiling: a discovery and reproducibility study.
    Noerman S; Virtanen JK; Lehtonen M; Brunius C; Hanhineva K
    Eur J Nutr; 2023 Mar; 62(2):713-726. PubMed ID: 36198920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study.
    Chevli PA; Freedman BI; Hsu FC; Xu J; Rudock ME; Ma L; Parks JS; Palmer ND; Shapiro MD
    Cardiovasc Diabetol; 2021 Dec; 20(1):231. PubMed ID: 34876126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.
    Würtz P; Havulinna AS; Soininen P; Tynkkynen T; Prieto-Merino D; Tillin T; Ghorbani A; Artati A; Wang Q; Tiainen M; Kangas AJ; Kettunen J; Kaikkonen J; Mikkilä V; Jula A; Kähönen M; Lehtimäki T; Lawlor DA; Gaunt TR; Hughes AD; Sattar N; Illig T; Adamski J; Wang TJ; Perola M; Ripatti S; Vasan RS; Raitakari OT; Gerszten RE; Casas JP; Chaturvedi N; Ala-Korpela M; Salomaa V
    Circulation; 2015 Mar; 131(9):774-85. PubMed ID: 25573147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Profiles and Heart Failure Risk in Black Adults: Insights From the Jackson Heart Study.
    Tahir UA; Katz DH; Zhao T; Ngo D; Cruz DE; Robbins JM; Chen ZZ; Peterson B; Benson MD; Shi X; Dailey L; Andersson C; Vasan RS; Gao Y; Shen C; Correa A; Hall ME; Wang TJ; Clish CB; Wilson JG; Gerszten RE
    Circ Heart Fail; 2021 Jan; 14(1):e007275. PubMed ID: 33464957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of leptin and adiponectin with incident type 2 diabetes and interactions among African Americans: the Jackson heart study.
    Bidulescu A; Dinh PC; Sarwary S; Forsyth E; Luetke MC; King DB; Liu J; Davis SK; Correa A
    BMC Endocr Disord; 2020 Mar; 20(1):31. PubMed ID: 32131811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Sickle Cell Trait With Hemoglobin A1c in African Americans.
    Lacy ME; Wellenius GA; Sumner AE; Correa A; Carnethon MR; Liem RI; Wilson JG; Sacks DB; Jacobs DR; Carson AP; Luo X; Gjelsvik A; Reiner AP; Naik RP; Liu S; Musani SK; Eaton CB; Wu WC
    JAMA; 2017 Feb; 317(5):507-515. PubMed ID: 28170479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum metabolomic profiling and incident CKD among African Americans.
    Yu B; Zheng Y; Nettleton JA; Alexander D; Coresh J; Boerwinkle E
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1410-7. PubMed ID: 25011442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Metabolomics of Incident Diabetes and Glycemic Changes in a Population With High Diabetes Burden: The Hispanic Community Health Study/Study of Latinos.
    Chai JC; Chen GC; Yu B; Xing J; Li J; Khambaty T; Perreira KM; Perera MJ; Vidot DC; Castaneda SF; Selvin E; Rebholz CM; Daviglus ML; Cai J; Van Horn L; Isasi CR; Sun Q; Hawkins M; Xue X; Boerwinkle E; Kaplan RC; Qi Q
    Diabetes; 2022 Jun; 71(6):1338-1349. PubMed ID: 35293992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts.
    Hu J; Yao J; Deng S; Balasubramanian R; Jiménez MC; Li J; Guo X; Cruz DE; Gao Y; Huang T; Zeleznik OA; Ngo D; Liu S; Rosal MC; Nassir R; Paynter NP; Albert CM; Tracy RP; Durda P; Liu Y; Taylor KD; Johnson WC; Sun Q; Rimm EB; Eliassen AH; Rich SS; Rotter JI; Gerszten RE; Clish CB; Rexrode KM
    Circ Res; 2022 Sep; 131(7):601-615. PubMed ID: 36052690
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.